Christine M. Klaskin, VP, Finance at ANTIGENICS INC /DE/ (AGEN), sold 2,500 shares at $1.21 ($3K) on 2010-04-26, disclosed to the SEC on 2010-04-28.
Scheduled sale ($3k) by VP, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ADGE | BUY | 2014-11-24 | $720 | — | Filing → |
| AGEN | SELL | 2011-12-29 | $19K | — | Filing → |
| AGEN | SELL | 2011-12-23 | $8K | — | Filing → |